Table 1 Clinical characteristics of SDAVF patients
Variables | Value |
|---|---|
Gender (female, n, %) | 15(33.3) |
Age (years) | 52.6 ± 14.3(17 ~ 75) |
Hypertension (n, %) | 14(31.1) |
Diabetes (n, %) | 8(17.7) |
Smoking (n, %) | 13(28.9) |
SDAVF location (n, %) | |
Cervical | 4(8.9) |
Thoracic | 26(57.8) |
Lumbar | 13(28.9) |
Sacrum | 2(4.4) |
Onset symptom (n, %) | |
Gait abnormality | 41(91.1) |
Sensory abnormality | 31(68.9) |
Urinary dysfunction | 27(60.0) |
SAH | 2(4.4) |
Surgical time (h) | 4.5 ± 0.6(3.5 ~ 8) |
Days of hospitalization (days) | 20.5 ± 8.5(11 ~ 35) |
mALS improvement rate (n, %) | |
1–2 days after surgery | 16(35.6) |
1 week after surgery | 12(26.7) |
Follow-up | 7(15.6) |
mALS outcome at follow-up (n, %) | |
Improved | 35(77.8) |
Unchanged | 8(17.8) |
Worsened | 2(4.4) |